EUVIMEDEUVIMED entdecken
Open Access

Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test

Darko Stefanovski, Dawn D Smiley, Naresh M Punjabi, Guillermo E Umpierrez, Priyathama Vellanki iD

The Journal of Clinical Endocrinology & Metabolism · 17.03.2025 · 110 (4) · e1108-e1115

DOI: 10.1210/clinem/dgae308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 13.05.2024. Verfasst von Darko Stefanovski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, PA 19348, USA. Hauptthemen laut MEDLINE: Insulin Resistance, Blood Glucose, Glucose, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Glucose tolerance during an oral glucose tolerance test (OGTT) is affected by variations in glucose effectiveness (GE) and glucose absorption and thus affects minimal model calculations of insulin sensitivity (SI). The widely used OGTT SI by Dalla Man et al does not account for variances in GE and glucose absorption.

Objective

To develop a novel model that concurrently assesses SI, GE, and glucose absorption.

Methods

In this cross-sectional study conducted at an academic medical center, 17 subjects without abnormalities on OGTT (controls) and 88 subjects with diabetes underwent a 75-gram 120-minute 6-timepoint OGTT. The SI from the Dalla Man model was validated with the novel model SI using Bland-Altman limits of agreement methodology. Comparisons of SI, GE, and gastrointestinal glucose half-life (GIGt1/2), a surrogate measure for glucose absorption, were made between subjects with diabetes and controls.

Results

In controls and diabetes, the novel model SI was higher than the current OGTT model. The SI from both controls (ƿ=0.90, P < .001) and diabetes (ƿ=0.77, P < .001) has high agreement between models. GE was higher in diabetes (median: 0.021 1/min, interquartile range [IQR]: 0.020-0.022) compared to controls (median: 0.016 1/min, IQR: 0.015-0.017), P = .02. GIGt1/2 was shorter in diabetes (median: 48.404 min, IQR: 54.424-39.426) than in controls (median: 55.086 min, IQR: 61.368-48.502) without statistical difference.

Conclusion

Our novel model SI has a good correlation with SI from the widely used Dalla Man's model while concurrently calculating GE and GIGt1/2. Thus, besides estimating SI, our novel model can quantify differences in insulin-independent glucose disposal mechanisms important for diabetes pathophysiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceBlood GlucoseGlucoseDiabetes Mellitus, Type 2HumansGlucose Tolerance TestMaleCross-Sectional StudiesFemaleMiddle AgedAdultGlucose IntoleranceAgedModels, Biological

Stichwörter der Autor:innen

OGTTglucose absorptionglucose effectivenessinsulin sensitivityminimal model

Substanzen

Blood GlucoseGlucose

Autor:innen und Institutionen

  • Department of Clinical Studies, New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, PA 19348, USA.
  • Department of Medicine, Division of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, GA 30308, USA.
  • Department of Medicine, Grady Health System, Atlanta, GA 30303, USA.
  • Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

ORCID-Profile: Priyathama Vellanki

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Stefanovski, D., Smiley, D. D., Punjabi, N. M., Umpierrez, G. E., & Vellanki, P. (2025). Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test. The Journal of Clinical Endocrinology & Metabolism, 110(4), e1108-e1115. https://doi.org/10.1210/clinem/dgae308

Vancouver

Stefanovski D, Smiley DD, Punjabi NM, Umpierrez GE, Vellanki P. Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test. The Journal of Clinical Endocrinology & Metabolism. 2025;110(4):e1108-e1115. doi:10.1210/clinem/dgae308

BibTeX
@article{Stefanovski2025,
  author = {Stefanovski, Darko and Smiley, Dawn D and Punjabi, Naresh M and Umpierrez, Guillermo E and Vellanki, Priyathama},
  title = {Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {4},
  pages = {e1108--e1115},
  doi = {10.1210/clinem/dgae308}
}
Kostenlos starten →